Shanxi C&Y Pharmaceutical Co.,Ltd. Posted 17.7 Million Yuan Net Loss in First Half of 2023

Shanxi C&Y Pharmaceutical Co.,Ltd. (山西仟源医药集团股份有限公司) (300254.SZ) reported a net loss of 17.7 million yuan in the first half of 2023, widening 224.7% year-on-year.

Meanwhile, the company posted 365.6 million yuan in revenue, down 9.7% year-on-year.

At the end of the reporting period, it had 1.7 billion yuan in total assets and 1 billion yuan in total liabilities, with a liability-to-asset ratio of 57.4%.